Security key
05070R104
- Security type / class
- Equity / COM
- Total 13F shares
- 15,960,466
- Total 13F value
- $271,964,916
- Share change
- +1,310,099
- SEC-reported price per share
- $17.04
- Number of holders
- 57
- Value change
- +$22,292,094
- Number of buys
- 26
- Number of sells
- 17
Report period
Q1 2017
Institutions
57
Top holders
10
BOLD full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2017
Previous quarter: Q4 2016
Boundless Bio, Inc. SEC filings
Boundless Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05070R104
Recent filing periods:
Ownership snapshot
Top reported holders of BOLD - AUDENTES THERAPEUTICS INC - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/15
Latest evidence
31 Dec 2016
13F
Highest disclosed value: $87,726,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC has the largest disclosed position value at $87.73M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value
Top 5
ORBIMED ADVISORS LLC
$87.73M
Versant Venture Management, LLC
$33.01M
DEERFIELD MANAGEMENT COMPANY, L.P.
$25.64M
Redmile Group, LLC
$15.21M
PRICE T ROWE ASSOCIATES INC /MD/
$10.27M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$87,726,000
4,801,638 shares
|
— | 31 Dec 2016 |
| Versant Venture Management, LLC |
13F
Company
|
—
class O/S missing
|
$33,010,821
1,806,832 shares
|
— | 31 Dec 2016 |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
Company
|
—
class O/S missing
|
$25,645,000
1,403,653 shares
|
— | 31 Dec 2016 |
| Redmile Group, LLC |
13F
Company
|
—
class O/S missing
|
$15,214,000
832,736 shares
|
— | 31 Dec 2016 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
—
class O/S missing
|
$10,267,000
578,597 shares
|
— | 31 Dec 2016 |
| ALLIANCEBERNSTEIN L.P. |
13F
Company
|
—
class O/S missing
|
$9,743,000
533,258 shares
|
— | 31 Dec 2016 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2017
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
57
Shares
15,960,466
Rows available
57
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
55
Q1 2017 holders
57
Holder diff
2
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 value | Q1 2017 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend